nodes	percent_of_prediction	percent_of_DWPC	metapath
Bendroflumethiazide—KCNMA1—ganglion—brain cancer	0.0434	0.0706	CbGeAlD
Bendroflumethiazide—KCNMA1—blood vessel—brain cancer	0.0345	0.0561	CbGeAlD
Bendroflumethiazide—KCNMA1—hindbrain—brain cancer	0.0329	0.0535	CbGeAlD
Bendroflumethiazide—Gastric irritation—Hydroxyurea—brain cancer	0.0325	0.0846	CcSEcCtD
Bendroflumethiazide—CA4—ganglion—brain cancer	0.0258	0.0419	CbGeAlD
Bendroflumethiazide—Epigastric discomfort—Hydroxyurea—brain cancer	0.024	0.0624	CcSEcCtD
Bendroflumethiazide—CA4—hindbrain—brain cancer	0.0196	0.0318	CbGeAlD
Bendroflumethiazide—KCNMA1—brainstem—brain cancer	0.0189	0.0307	CbGeAlD
Bendroflumethiazide—TPMT—telencephalon—brain cancer	0.018	0.0293	CbGeAlD
Bendroflumethiazide—KCNMA1—telencephalon—brain cancer	0.0168	0.0272	CbGeAlD
Bendroflumethiazide—CA2—hindbrain—brain cancer	0.0162	0.0263	CbGeAlD
Bendroflumethiazide—TPMT—gonad—brain cancer	0.015	0.0244	CbGeAlD
Bendroflumethiazide—TPMT—pituitary gland—brain cancer	0.0147	0.0238	CbGeAlD
Bendroflumethiazide—TPMT—medulla oblongata—brain cancer	0.0141	0.023	CbGeAlD
Bendroflumethiazide—KCNMA1—gonad—brain cancer	0.014	0.0227	CbGeAlD
Bendroflumethiazide—Vascular purpura—Procarbazine—brain cancer	0.0132	0.0344	CcSEcCtD
Bendroflumethiazide—TPMT—midbrain—brain cancer	0.0129	0.021	CbGeAlD
Bendroflumethiazide—CA1—telencephalon—brain cancer	0.0127	0.0207	CbGeAlD
Bendroflumethiazide—TPMT—spinal cord—brain cancer	0.0126	0.0205	CbGeAlD
Bendroflumethiazide—Purpura—Procarbazine—brain cancer	0.0123	0.0319	CcSEcCtD
Bendroflumethiazide—KCNMA1—midbrain—brain cancer	0.012	0.0195	CbGeAlD
Bendroflumethiazide—TPMT—endocrine gland—brain cancer	0.0114	0.0185	CbGeAlD
Bendroflumethiazide—TPMT—head—brain cancer	0.0112	0.0182	CbGeAlD
Bendroflumethiazide—CA4—brainstem—brain cancer	0.0112	0.0182	CbGeAlD
Bendroflumethiazide—Drug interaction—Carmustine—brain cancer	0.011	0.0286	CcSEcCtD
Bendroflumethiazide—KCNMA1—endocrine gland—brain cancer	0.0106	0.0172	CbGeAlD
Bendroflumethiazide—KCNMA1—head—brain cancer	0.0104	0.0169	CbGeAlD
Bendroflumethiazide—TPMT—central nervous system—brain cancer	0.0102	0.0166	CbGeAlD
Bendroflumethiazide—Pancreatitis—Procarbazine—brain cancer	0.01	0.0261	CcSEcCtD
Bendroflumethiazide—TPMT—cerebellum—brain cancer	0.01	0.0163	CbGeAlD
Bendroflumethiazide—CA4—telencephalon—brain cancer	0.00995	0.0162	CbGeAlD
Bendroflumethiazide—KCNMA1—central nervous system—brain cancer	0.00952	0.0155	CbGeAlD
Bendroflumethiazide—KCNMA1—cerebellum—brain cancer	0.00931	0.0151	CbGeAlD
Bendroflumethiazide—CA2—brainstem—brain cancer	0.00929	0.0151	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Lomustine—brain cancer	0.00897	0.0233	CcSEcCtD
Bendroflumethiazide—CA1—spinal cord—brain cancer	0.00892	0.0145	CbGeAlD
Bendroflumethiazide—Anorexia—Lomustine—brain cancer	0.00873	0.0227	CcSEcCtD
Bendroflumethiazide—Diabetes mellitus—Carmustine—brain cancer	0.00851	0.0221	CcSEcCtD
Bendroflumethiazide—CA2—telencephalon—brain cancer	0.00825	0.0134	CbGeAlD
Bendroflumethiazide—TPMT—brain—brain cancer	0.00812	0.0132	CbGeAlD
Bendroflumethiazide—CA4—pituitary gland—brain cancer	0.0081	0.0132	CbGeAlD
Bendroflumethiazide—CA1—endocrine gland—brain cancer	0.00803	0.013	CbGeAlD
Bendroflumethiazide—Vascular purpura—Temozolomide—brain cancer	0.008	0.0208	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Lomustine—brain cancer	0.00796	0.0207	CcSEcCtD
Bendroflumethiazide—CA1—head—brain cancer	0.00792	0.0129	CbGeAlD
Bendroflumethiazide—CA4—medulla oblongata—brain cancer	0.00782	0.0127	CbGeAlD
Bendroflumethiazide—Pancreatitis—Hydroxyurea—brain cancer	0.00776	0.0202	CcSEcCtD
Bendroflumethiazide—KCNMA1—brain—brain cancer	0.00756	0.0123	CbGeAlD
Bendroflumethiazide—Thirst—Temozolomide—brain cancer	0.00752	0.0195	CcSEcCtD
Bendroflumethiazide—Purpura—Temozolomide—brain cancer	0.00742	0.0193	CcSEcCtD
Bendroflumethiazide—CA1—central nervous system—brain cancer	0.00723	0.0118	CbGeAlD
Bendroflumethiazide—CA4—midbrain—brain cancer	0.00714	0.0116	CbGeAlD
Bendroflumethiazide—CA4—spinal cord—brain cancer	0.00697	0.0113	CbGeAlD
Bendroflumethiazide—Hypokalaemia—Carmustine—brain cancer	0.00674	0.0175	CcSEcCtD
Bendroflumethiazide—CA2—pituitary gland—brain cancer	0.00672	0.0109	CbGeAlD
Bendroflumethiazide—Hypokalaemia—Temozolomide—brain cancer	0.00651	0.0169	CcSEcCtD
Bendroflumethiazide—CA2—medulla oblongata—brain cancer	0.00648	0.0105	CbGeAlD
Bendroflumethiazide—CA4—endocrine gland—brain cancer	0.00627	0.0102	CbGeAlD
Bendroflumethiazide—CA4—head—brain cancer	0.00619	0.0101	CbGeAlD
Bendroflumethiazide—CA2—midbrain—brain cancer	0.00592	0.00962	CbGeAlD
Bendroflumethiazide—Vomiting—Lomustine—brain cancer	0.00582	0.0151	CcSEcCtD
Bendroflumethiazide—CA2—spinal cord—brain cancer	0.00578	0.00939	CbGeAlD
Bendroflumethiazide—CA1—brain—brain cancer	0.00574	0.00933	CbGeAlD
Bendroflumethiazide—Erectile dysfunction—Temozolomide—brain cancer	0.00569	0.0148	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Procarbazine—brain cancer	0.00569	0.0148	CcSEcCtD
Bendroflumethiazide—CA4—central nervous system—brain cancer	0.00565	0.00919	CbGeAlD
Bendroflumethiazide—Anorexia—Procarbazine—brain cancer	0.00554	0.0144	CcSEcCtD
Bendroflumethiazide—CA4—cerebellum—brain cancer	0.00553	0.00898	CbGeAlD
Bendroflumethiazide—Nausea—Lomustine—brain cancer	0.00544	0.0141	CcSEcCtD
Bendroflumethiazide—Hypotension—Procarbazine—brain cancer	0.00543	0.0141	CcSEcCtD
Bendroflumethiazide—CA2—endocrine gland—brain cancer	0.0052	0.00845	CbGeAlD
Bendroflumethiazide—Cramp muscle—Etoposide—brain cancer	0.00515	0.0134	CcSEcCtD
Bendroflumethiazide—CA2—head—brain cancer	0.00514	0.00834	CbGeAlD
Bendroflumethiazide—Decreased appetite—Procarbazine—brain cancer	0.00505	0.0131	CcSEcCtD
Bendroflumethiazide—Constipation—Procarbazine—brain cancer	0.00497	0.0129	CcSEcCtD
Bendroflumethiazide—CA2—central nervous system—brain cancer	0.00469	0.00762	CbGeAlD
Bendroflumethiazide—CA2—cerebellum—brain cancer	0.00458	0.00744	CbGeAlD
Bendroflumethiazide—CA4—brain—brain cancer	0.00449	0.00729	CbGeAlD
Bendroflumethiazide—Thrombocytopenia—Hydroxyurea—brain cancer	0.00441	0.0115	CcSEcCtD
Bendroflumethiazide—Anorexia—Hydroxyurea—brain cancer	0.00429	0.0112	CcSEcCtD
Bendroflumethiazide—Asthenia—Procarbazine—brain cancer	0.00417	0.0108	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Procarbazine—brain cancer	0.00398	0.0103	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Hydroxyurea—brain cancer	0.00391	0.0102	CcSEcCtD
Bendroflumethiazide—Constipation—Hydroxyurea—brain cancer	0.00385	0.01	CcSEcCtD
Bendroflumethiazide—Dizziness—Procarbazine—brain cancer	0.00384	0.01	CcSEcCtD
Bendroflumethiazide—CA2—brain—brain cancer	0.00372	0.00605	CbGeAlD
Bendroflumethiazide—Vomiting—Procarbazine—brain cancer	0.0037	0.00961	CcSEcCtD
Bendroflumethiazide—Rash—Procarbazine—brain cancer	0.00367	0.00953	CcSEcCtD
Bendroflumethiazide—Dermatitis—Procarbazine—brain cancer	0.00366	0.00953	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Carmustine—brain cancer	0.00356	0.00926	CcSEcCtD
Bendroflumethiazide—Anorexia—Carmustine—brain cancer	0.00347	0.00902	CcSEcCtD
Bendroflumethiazide—Nausea—Procarbazine—brain cancer	0.00345	0.00898	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Temozolomide—brain cancer	0.00344	0.00895	CcSEcCtD
Bendroflumethiazide—Hypotension—Carmustine—brain cancer	0.0034	0.00884	CcSEcCtD
Bendroflumethiazide—Anorexia—Temozolomide—brain cancer	0.00335	0.00871	CcSEcCtD
Bendroflumethiazide—Muscle spasms—Etoposide—brain cancer	0.00331	0.00862	CcSEcCtD
Bendroflumethiazide—Asthenia—Hydroxyurea—brain cancer	0.00323	0.0084	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Carmustine—brain cancer	0.00316	0.00822	CcSEcCtD
Bendroflumethiazide—Constipation—Carmustine—brain cancer	0.00311	0.00809	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Hydroxyurea—brain cancer	0.00308	0.00801	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Temozolomide—brain cancer	0.00306	0.00795	CcSEcCtD
Bendroflumethiazide—Constipation—Temozolomide—brain cancer	0.00301	0.00782	CcSEcCtD
Bendroflumethiazide—Dizziness—Hydroxyurea—brain cancer	0.00298	0.00774	CcSEcCtD
Bendroflumethiazide—Vomiting—Hydroxyurea—brain cancer	0.00286	0.00744	CcSEcCtD
Bendroflumethiazide—Rash—Hydroxyurea—brain cancer	0.00284	0.00738	CcSEcCtD
Bendroflumethiazide—Dermatitis—Hydroxyurea—brain cancer	0.00283	0.00737	CcSEcCtD
Bendroflumethiazide—Thrombocytopenia—Etoposide—brain cancer	0.00275	0.00716	CcSEcCtD
Bendroflumethiazide—Anorexia—Etoposide—brain cancer	0.00268	0.00697	CcSEcCtD
Bendroflumethiazide—Nausea—Hydroxyurea—brain cancer	0.00267	0.00695	CcSEcCtD
Bendroflumethiazide—Hypotension—Etoposide—brain cancer	0.00263	0.00684	CcSEcCtD
Bendroflumethiazide—Asthenia—Carmustine—brain cancer	0.00261	0.00679	CcSEcCtD
Bendroflumethiazide—Asthenia—Temozolomide—brain cancer	0.00252	0.00656	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Carmustine—brain cancer	0.00249	0.00647	CcSEcCtD
Bendroflumethiazide—Decreased appetite—Etoposide—brain cancer	0.00245	0.00636	CcSEcCtD
Bendroflumethiazide—Dizziness—Carmustine—brain cancer	0.00241	0.00626	CcSEcCtD
Bendroflumethiazide—Constipation—Etoposide—brain cancer	0.00241	0.00626	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Temozolomide—brain cancer	0.00241	0.00626	CcSEcCtD
Bendroflumethiazide—Dizziness—Temozolomide—brain cancer	0.00232	0.00605	CcSEcCtD
Bendroflumethiazide—Vomiting—Carmustine—brain cancer	0.00231	0.00601	CcSEcCtD
Bendroflumethiazide—Rash—Carmustine—brain cancer	0.00229	0.00596	CcSEcCtD
Bendroflumethiazide—Dermatitis—Carmustine—brain cancer	0.00229	0.00596	CcSEcCtD
Bendroflumethiazide—Vomiting—Temozolomide—brain cancer	0.00224	0.00581	CcSEcCtD
Bendroflumethiazide—Rash—Temozolomide—brain cancer	0.00222	0.00576	CcSEcCtD
Bendroflumethiazide—Dermatitis—Temozolomide—brain cancer	0.00221	0.00576	CcSEcCtD
Bendroflumethiazide—Nausea—Carmustine—brain cancer	0.00216	0.00562	CcSEcCtD
Bendroflumethiazide—Nausea—Temozolomide—brain cancer	0.00209	0.00543	CcSEcCtD
Bendroflumethiazide—Asthenia—Etoposide—brain cancer	0.00202	0.00525	CcSEcCtD
Bendroflumethiazide—Diarrhoea—Etoposide—brain cancer	0.00192	0.00501	CcSEcCtD
Bendroflumethiazide—Dizziness—Etoposide—brain cancer	0.00186	0.00484	CcSEcCtD
Bendroflumethiazide—Vomiting—Etoposide—brain cancer	0.00179	0.00465	CcSEcCtD
Bendroflumethiazide—Rash—Etoposide—brain cancer	0.00177	0.00461	CcSEcCtD
Bendroflumethiazide—Dermatitis—Etoposide—brain cancer	0.00177	0.00461	CcSEcCtD
Bendroflumethiazide—Nausea—Etoposide—brain cancer	0.00167	0.00435	CcSEcCtD
